Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 12—December 2025
Dispatch
West Nile Virus–Associated Hemophagocytic Lymphohistiocytosis, Switzerland
Figure 1

Figure 1. Evolution of laboratory data for a patient with West Nile virus–associated hemophagocytic lymphohistiocytosis during hospitalization, Geneva, Switzerland. Results include C-reactive protein, ferritin, thrombocytes, leukocytes, and triglycerides. Pink shading indicates corticosteroid treatment.
Page created: November 17, 2025
Page updated: December 12, 2025
Page reviewed: December 12, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.